Drug name - Acular Ls

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8008338 ALLERGAN Ketorolac tromethamine compositions for treating or preventing ocular pain
May, 2027

(4 years from now)

EP3217937A4 ALLERGAN Bed Systems And Methods
Nov, 2035

(13 years from now)

EP3217937A1 ALLERGAN Bed Systems
Nov, 2035

(13 years from now)

EP3217937B1 ALLERGAN Bed Systems
Nov, 2035

(13 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8541463 ALLERGAN Ketorolac tromethamine compositions for treating or preventing ocular pain May, 2024

(1 year, 7 months from now)

US8377982 ALLERGAN Ketorolac tromethamine compositions for treating or preventing ocular pain May, 2024

(1 year, 7 months from now)

US9216167 ALLERGAN Ketorolac tromethamine compositions for treating or preventing ocular pain May, 2024

(1 year, 7 months from now)

US8207215 ALLERGAN Ketorolac tromethamine compositions for treating or preventing ocular pain May, 2024

(1 year, 7 months from now)

US8648107 ALLERGAN Ketorolac tromethamine compositions for treating or preventing ocular pain May, 2024

(1 year, 7 months from now)

US8906950 ALLERGAN Ketorolac tromethamine compositions for treating or preventing ocular pain May, 2024

(1 year, 7 months from now)

US8946281 ALLERGAN Ketorolac tromethamine compositions for treating or preventing ocular pain May, 2024

(1 year, 7 months from now)

US8377982

(Pediatric)

ALLERGAN Ketorolac tromethamine compositions for treating or preventing ocular pain Nov, 2024

(2 years from now)

US8541463

(Pediatric)

ALLERGAN Ketorolac tromethamine compositions for treating or preventing ocular pain Nov, 2024

(2 years from now)

US8207215

(Pediatric)

ALLERGAN Ketorolac tromethamine compositions for treating or preventing ocular pain Nov, 2024

(2 years from now)

US8008338

(Pediatric)

ALLERGAN Ketorolac tromethamine compositions for treating or preventing ocular pain Nov, 2027

(5 years from now)

Drugs and Companies using KETOROLAC TROMETHAMINE ingredient

Treatment: A method of treating or reducing ocular pain and burning/stinging; A method of treating or preventing ocular pain and burning/stinging following corneal surgery; A method of treating ocular pain and/or enhancing ocular comfort; A method of controlling postoperative ocular pain and burning/stinging in a patient; A method of treating or preventing ocular pain and burning; A method of treating ocular pain

Dosage: SOLUTION/DROPS;OPHTHALMIC

More Information on Dosage
Strength Dosage Availability
0.4% SOLUTION/DROPS;OPHTHALMIC Prescription

availability in other generic markets.

Click on the highlighted region to filter.